Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells-Reference-Cited by-同舟云学术

Cytokeratin 19 (KRT19) has a Role in the Reprogramming of Cancer Stem Cell-Like Cells to Less Aggressive and More Drug-Sensitive Cells

Published:2018-05-09 Issue:5 Volume:19 Page:1423
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Saha Subbroto,Kim Kyeongseok,Yang Gwang-Mo,Choi Hye,Cho Ssang-Goo^ORCID

Publisher

MDPI AG

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Computer Science Applications,Spectroscopy,Molecular Biology,General Medicine,Catalysis

Link

http://www.mdpi.com/1422-0067/19/5/1423/pdf

Reference98 articles.

1. Cellular Heterogeneity and Molecular Evolution in Cancer

2. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

3. Cancer Genetics and Epigenetics: Two Sides of the Same Coin?

4. Stem cells, cancer, and cancer stem cells

5. Molecular barriers to processes of genetic reprogramming and cell transformation

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KRT19 is regulated by miR-642a-5p and promotes pancreatic cancer progression through the Wnt/β-catenin pathway;iScience;2024-09

2. STAU1-mediated CNBP mRNA degradation by LINC00665 alters stem cell characteristics in ovarian cancer;Biology Direct;2024-07-30

3. RNA-Seq transcriptome profiling of Nile rat livers reveals novel insights on the anti-diabetic mechanisms of Water-Soluble Palm Fruit Extract;Journal of Applied Genetics;2024-06-18

4. Unraveling metabolic characteristics and clinical implications in gastric cancer through single-cell resolution analysis;Frontiers in Molecular Biosciences;2024-05-20

5. Integrated bioinformatics analysis reveals upregulated extracellular matrix hub genes in pancreatic cancer: Implications for diagnosis, prognosis, immune infiltration, and therapeutic strategies;Cancer Reports;2024-04